Share Price and Basic Stock Data
Last Updated: November 22, 2025, 7:57 am
| PEG Ratio | 2.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambuja Cements Ltd, a leading player in the Indian cement industry, reported a market capitalization of ₹1,37,297 Cr and a stock price of ₹555. The company has exhibited a consistent revenue trajectory, with sales rising from ₹8,033 Cr in Jun 2022 to ₹8,713 Cr in Jun 2023. The latest quarterly sales figures for Dec 2023 stood at ₹8,129 Cr, reflecting a continued demand for cement. The trailing twelve months (TTM) revenue reached ₹38,773 Cr, showcasing resilience amid fluctuating market conditions. Over the years, Ambuja’s annual sales have grown significantly, from ₹9,161 Cr in Dec 2013 to ₹38,937 Cr in Mar 2023, indicating a robust growth strategy. The company’s ability to maintain a steady revenue stream suggests effective operational management and a strong market presence, particularly in the context of India’s booming infrastructure sector.
Profitability and Efficiency Metrics
Ambuja Cements reported a net profit of ₹7,222 Cr for the most recent fiscal year, with a profit margin of 14.68% as of Mar 2025. The operating profit margin (OPM) has shown an upward trend, rising to 19% in the latest reporting period, reflecting improved cost management and operational efficiency. The interest coverage ratio (ICR) stood at a strong 45.06x, indicating the company’s ability to meet its interest obligations comfortably. Return on equity (ROE) was reported at 8.73%, while return on capital employed (ROCE) was 10.5%, both of which are competitive within the sector. However, the company’s cash conversion cycle (CCC) of 100 days suggests room for improvement in working capital management. Overall, Ambuja’s profitability metrics are commendable, demonstrating a solid financial foundation in a capital-intensive industry.
Balance Sheet Strength and Financial Ratios
Ambuja Cements maintains a robust balance sheet, with total assets amounting to ₹80,941 Cr as of Mar 2025. The company’s reserves have significantly increased to ₹55,752 Cr, providing a strong buffer for future growth initiatives and absorbing potential shocks. Borrowings stood at ₹1,271 Cr, indicating a conservative approach to leverage, which is well-supported by the strong interest coverage ratio. The price-to-book value (P/BV) ratio was recorded at 2.96x, reflecting investor confidence in the company’s valuation relative to its book value. Additionally, the current ratio of 1.42x suggests healthy liquidity levels, enabling the company to meet short-term obligations effectively. These factors collectively portray Ambuja Cements as a financially sound entity, capable of sustaining its operations and investments in a competitive market.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambuja Cements reflects a stable investor base, with promoters holding 67.68% of the shares as of Sep 2025. This strong promoter stake indicates a commitment to the company’s long-term vision. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 5.91% and 19.41% respectively, demonstrating confidence in the company’s prospects. However, FIIs have seen a decline in their holdings from 10.66% in Dec 2022 to 5.91% in Sep 2025, which may raise concerns regarding foreign investor sentiment. Conversely, the increase in DII holdings from 16.71% in Dec 2022 to 19.41% in Sep 2025 suggests a growing domestic interest. The total number of shareholders stood at 620,457, highlighting a solid retail investor base, which is crucial for liquidity and market stability.
Outlook, Risks, and Final Insight
Ambuja Cements is poised for growth, driven by India’s ongoing infrastructure development projects and rising cement demand. However, the company faces risks, including fluctuations in raw material prices and potential disruptions in supply chains. Additionally, the decline in FIIs’ stake may indicate a shift in foreign investor sentiment. Despite these challenges, the company’s strong financial metrics, including a robust interest coverage ratio and increasing reserves, position it favorably for future opportunities. If the company can enhance its working capital efficiency and mitigate risks associated with external factors, it is likely to sustain its growth trajectory. Conversely, any adverse economic conditions or regulatory changes could impact its performance. Overall, Ambuja Cements presents a compelling case for investors seeking exposure to the Indian cement sector, with a balanced outlook dependent on effective risk management strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambuja Cements Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 24.0/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,45,579 Cr. | 11,729 | 13,102/10,048 | 47.1 | 2,444 | 0.66 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 23,876 Cr. | 1,010 | 1,209/788 | 124 | 322 | 0.20 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 12,509 Cr. | 404 | 430/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 9,082 Cr. | 224 | 309/172 | 30.0 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 35,973.19 Cr | 1,908.15 | 37.58 | 573.56 | 0.53% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,033 | 7,143 | 7,907 | 7,966 | 8,713 | 7,424 | 8,129 | 8,894 | 8,392 | 7,516 | 9,329 | 9,981 | 10,289 |
| Expenses | 6,922 | 6,809 | 6,885 | 6,727 | 7,046 | 6,122 | 6,397 | 7,195 | 7,112 | 6,405 | 7,617 | 8,113 | 8,328 |
| Operating Profit | 1,111 | 334 | 1,021 | 1,239 | 1,667 | 1,302 | 1,732 | 1,699 | 1,280 | 1,111 | 1,712 | 1,868 | 1,961 |
| OPM % | 14% | 5% | 13% | 16% | 19% | 18% | 21% | 19% | 15% | 15% | 18% | 19% | 19% |
| Other Income | 143 | 75 | -18 | 142 | 268 | 480 | 204 | 448 | 358 | 220 | 1,355 | 713 | 300 |
| Interest | 40 | 41 | 43 | 39 | 52 | 61 | 70 | 93 | 68 | 67 | 67 | 14 | 67 |
| Depreciation | 319 | 331 | 337 | 352 | 372 | 381 | 416 | 459 | 476 | 552 | 664 | 786 | 862 |
| Profit before tax | 895 | 39 | 623 | 989 | 1,512 | 1,340 | 1,450 | 1,595 | 1,094 | 713 | 2,336 | 1,780 | 1,333 |
| Tax % | 3% | -33% | 22% | 23% | 25% | 26% | 25% | 5% | 28% | 34% | -12% | 28% | 27% |
| Net Profit | 865 | 51 | 488 | 763 | 1,135 | 987 | 1,091 | 1,521 | 783 | 473 | 2,620 | 1,282 | 970 |
| EPS in Rs | 3.79 | 0.47 | 2.19 | 3.25 | 4.56 | 3.99 | 4.15 | 4.78 | 2.60 | 1.85 | 8.59 | 3.88 | 3.20 |
Last Updated: August 2, 2025, 12:25 am
Below is a detailed analysis of the quarterly data for Ambuja Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 10,289.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,981.00 Cr. (Mar 2025) to 10,289.00 Cr., marking an increase of 308.00 Cr..
- For Expenses, as of Jun 2025, the value is 8,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,113.00 Cr. (Mar 2025) to 8,328.00 Cr., marking an increase of 215.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 1,961.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,868.00 Cr. (Mar 2025) to 1,961.00 Cr., marking an increase of 93.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
- For Other Income, as of Jun 2025, the value is 300.00 Cr.. The value appears to be declining and may need further review. It has decreased from 713.00 Cr. (Mar 2025) to 300.00 Cr., marking a decrease of 413.00 Cr..
- For Interest, as of Jun 2025, the value is 67.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 53.00 Cr..
- For Depreciation, as of Jun 2025, the value is 862.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 786.00 Cr. (Mar 2025) to 862.00 Cr., marking an increase of 76.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 1,333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,780.00 Cr. (Mar 2025) to 1,333.00 Cr., marking a decrease of 447.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 27.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 970.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,282.00 Cr. (Mar 2025) to 970.00 Cr., marking a decrease of 312.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.20. The value appears to be declining and may need further review. It has decreased from 3.88 (Mar 2025) to 3.20, marking a decrease of 0.68.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:47 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,161 | 9,955 | 9,437 | 20,094 | 23,609 | 26,041 | 27,104 | 24,516 | 28,965 | 38,937 | 33,160 | 35,045 | 38,773 |
| Expenses | 7,492 | 8,022 | 7,895 | 16,913 | 19,751 | 22,030 | 22,507 | 19,511 | 22,755 | 33,815 | 26,760 | 29,074 | 31,471 |
| Operating Profit | 1,669 | 1,934 | 1,542 | 3,181 | 3,858 | 4,011 | 4,597 | 5,006 | 6,210 | 5,122 | 6,400 | 5,971 | 7,301 |
| OPM % | 18% | 19% | 16% | 16% | 16% | 15% | 17% | 20% | 21% | 13% | 19% | 17% | 19% |
| Other Income | 390 | 419 | 353 | 441 | 335 | 232 | 601 | 288 | 252 | 447 | 1,401 | 2,646 | 2,407 |
| Interest | 67 | 66 | 92 | 153 | 206 | 170 | 170 | 140 | 146 | 195 | 276 | 216 | 225 |
| Depreciation | 494 | 513 | 630 | 1,461 | 1,219 | 1,154 | 1,153 | 1,162 | 1,152 | 1,645 | 1,628 | 2,478 | 3,134 |
| Profit before tax | 1,498 | 1,774 | 1,173 | 2,008 | 2,768 | 2,919 | 3,875 | 3,992 | 5,164 | 3,729 | 5,896 | 5,922 | 6,349 |
| Tax % | 15% | 16% | 31% | 29% | 30% | -2% | 28% | 22% | 28% | 19% | 20% | 13% | |
| Net Profit | 1,278 | 1,487 | 808 | 1,434 | 1,945 | 2,973 | 2,783 | 3,107 | 3,711 | 3,024 | 4,735 | 5,158 | 7,222 |
| EPS in Rs | 8.27 | 9.59 | 5.21 | 5.57 | 7.64 | 10.97 | 10.55 | 11.91 | 14.00 | 13.01 | 16.26 | 16.92 | 23.00 |
| Dividend Payout % | 44% | 46% | 54% | 50% | 47% | 14% | 14% | 151% | 45% | 19% | 12% | 12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 8.93% |
| Change in YoY Net Profit Growth (%) | 0.00% |
Ambuja Cements Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 22% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 4, 2025, 11:10 pm
Balance Sheet
Last Updated: November 9, 2025, 1:37 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 309 | 310 | 310 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 440 | 493 | 494 |
| Reserves | 9,153 | 9,760 | 9,961 | 19,424 | 20,275 | 21,973 | 23,681 | 22,360 | 24,957 | 31,301 | 41,012 | 52,951 | 55,752 |
| Borrowings | 48 | 34 | 35 | 29 | 24 | 40 | 41 | 471 | 477 | 523 | 699 | 788 | 1,271 |
| Other Liabilities | 3,446 | 3,774 | 3,827 | 12,974 | 14,813 | 14,981 | 16,059 | 16,490 | 19,374 | 19,501 | 22,916 | 26,709 | 31,193 |
| Total Liabilities | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 | 88,710 |
| Fixed Assets | 6,147 | 6,310 | 6,170 | 21,410 | 20,898 | 20,636 | 20,701 | 20,486 | 22,254 | 23,551 | 32,194 | 42,578 | 56,540 |
| CWIP | 698 | 692 | 416 | 582 | 667 | 1,008 | 1,554 | 2,422 | 2,168 | 2,526 | 2,658 | 9,886 | 10,473 |
| Investments | 1,714 | 2,097 | 2,149 | 175 | 153 | 133 | 150 | 167 | 198 | 214 | 849 | 1,912 | 104 |
| Other Assets | 4,399 | 4,780 | 5,398 | 10,657 | 13,791 | 15,613 | 17,773 | 16,643 | 20,585 | 25,430 | 29,365 | 26,566 | 21,594 |
| Total Assets | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 | 88,710 |
Below is a detailed analysis of the balance sheet data for Ambuja Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 494.00 Cr.. The value appears strong and on an upward trend. It has increased from 493.00 Cr. (Mar 2025) to 494.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 55,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 52,951.00 Cr. (Mar 2025) to 55,752.00 Cr., marking an increase of 2,801.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,271.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 788.00 Cr. (Mar 2025) to 1,271.00 Cr., marking an increase of 483.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 31,193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26,709.00 Cr. (Mar 2025) to 31,193.00 Cr., marking an increase of 4,484.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 88,710.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80,941.00 Cr. (Mar 2025) to 88,710.00 Cr., marking an increase of 7,769.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 56,540.00 Cr.. The value appears strong and on an upward trend. It has increased from 42,578.00 Cr. (Mar 2025) to 56,540.00 Cr., marking an increase of 13,962.00 Cr..
- For CWIP, as of Sep 2025, the value is 10,473.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,886.00 Cr. (Mar 2025) to 10,473.00 Cr., marking an increase of 587.00 Cr..
- For Investments, as of Sep 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,912.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 1,808.00 Cr..
- For Other Assets, as of Sep 2025, the value is 21,594.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26,566.00 Cr. (Mar 2025) to 21,594.00 Cr., marking a decrease of 4,972.00 Cr..
- For Total Assets, as of Sep 2025, the value is 88,710.00 Cr.. The value appears strong and on an upward trend. It has increased from 80,941.00 Cr. (Mar 2025) to 88,710.00 Cr., marking an increase of 7,769.00 Cr..
Notably, the Reserves (55,752.00 Cr.) exceed the Borrowings (1,271.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -47.00 | -33.00 | -34.00 | -26.00 | -21.00 | -36.00 | -37.00 | -466.00 | -471.00 | 5.00 | -693.00 | -783.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 8 | 11 | 17 | 14 | 18 | 14 | 8 | 8 | 11 | 13 | 17 |
| Inventory Days | 419 | 379 | 394 | 339 | 323 | 333 | 208 | 193 | 337 | 234 | 238 | 238 |
| Days Payable | 251 | 265 | 299 | 324 | 370 | 339 | 231 | 259 | 359 | 198 | 196 | 154 |
| Cash Conversion Cycle | 176 | 123 | 107 | 32 | -33 | 13 | -9 | -58 | -14 | 46 | 56 | 100 |
| Working Capital Days | -54 | -61 | -65 | -67 | -62 | -34 | -56 | -80 | -74 | 45 | 8 | -22 |
| ROCE % | 16% | 18% | 11% | 11% | 12% | 12% | 14% | 14% | 17% | 12% | 13% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Mirae Asset Large Cap Fund | 9,478,894 | 1.4 | 531.1 | 9,478,894 | 2025-04-22 17:25:42 | 0% |
| Mirae Asset ELSS Tax Saver Fund | 6,828,859 | 1.83 | 382.62 | 6,828,859 | 2025-04-22 17:25:42 | 0% |
| ICICI Prudential Equity - Arbitrage Fund | 4,107,600 | 1.41 | 230.15 | 4,107,600 | 2025-04-22 17:25:42 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 3,819,600 | 0.59 | 214.01 | 3,819,600 | 2025-04-22 17:25:42 | 0% |
| Kotak Balanced Advantage Fund | 3,712,800 | 1.33 | 208.03 | 3,712,800 | 2025-04-22 17:25:42 | 0% |
| Nippon India Arbitrage Fund | 3,186,000 | 1.37 | 178.51 | 3,186,000 | 2025-04-22 17:25:42 | 0% |
| SBI Arbitrage Opportunities Fund | 3,164,400 | 0.67 | 177.3 | 3,164,400 | 2025-04-22 17:25:42 | 0% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 3,038,765 | 1.14 | 170.26 | 3,038,765 | 2025-04-22 17:25:42 | 0% |
| HDFC Large and Mid Cap Fund - Regular Plan | 2,949,329 | 1.03 | 165.25 | 2,949,329 | 2025-04-22 17:25:42 | 0% |
| Kotak Multicap Fund | 2,828,789 | 1.77 | 158.5 | 2,828,789 | 2025-04-22 17:25:42 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 17.00 | 17.99 | 13.01 | 14.00 | 11.91 |
| Diluted EPS (Rs.) | 16.96 | 16.67 | 12.64 | 14.00 | 11.91 |
| Cash EPS (Rs.) | 30.95 | 28.84 | 23.37 | 24.39 | 21.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Revenue From Operations / Share (Rs.) | 142.28 | 150.88 | 196.09 | 145.87 | 123.47 |
| PBDIT / Share (Rs.) | 35.02 | 34.43 | 29.51 | 33.05 | 27.47 |
| PBIT / Share (Rs.) | 24.95 | 27.04 | 21.23 | 27.25 | 21.62 |
| PBT / Share (Rs.) | 23.99 | 26.74 | 18.64 | 25.91 | 20.03 |
| Net Profit / Share (Rs.) | 20.89 | 21.45 | 15.09 | 18.59 | 15.57 |
| NP After MI And SOA / Share (Rs.) | 16.92 | 16.27 | 13.01 | 14.00 | 11.91 |
| PBDIT Margin (%) | 24.61 | 22.81 | 15.05 | 22.65 | 22.25 |
| PBIT Margin (%) | 17.53 | 17.92 | 10.82 | 18.67 | 17.51 |
| PBT Margin (%) | 16.86 | 17.72 | 9.50 | 17.75 | 16.22 |
| Net Profit Margin (%) | 14.68 | 14.21 | 7.69 | 12.74 | 12.61 |
| NP After MI And SOA Margin (%) | 11.89 | 10.78 | 6.63 | 9.59 | 9.64 |
| Return on Networth / Equity (%) | 7.79 | 8.62 | 8.14 | 10.96 | 10.39 |
| Return on Capital Employeed (%) | 9.16 | 11.17 | 10.48 | 15.92 | 14.09 |
| Return On Assets (%) | 5.14 | 5.47 | 4.99 | 6.15 | 5.95 |
| Asset Turnover Ratio (%) | 0.47 | 0.56 | 0.49 | 0.41 | 0.34 |
| Current Ratio (X) | 1.42 | 2.05 | 1.67 | 1.52 | 1.38 |
| Quick Ratio (X) | 1.12 | 1.75 | 1.39 | 1.27 | 1.20 |
| Inventory Turnover Ratio (X) | 3.58 | 3.61 | 3.51 | 2.93 | 2.20 |
| Dividend Payout Ratio (NP) (%) | 11.82 | 13.87 | 48.42 | 0.00 | 142.70 |
| Dividend Payout Ratio (CP) (%) | 7.41 | 9.54 | 29.58 | 0.00 | 95.70 |
| Earning Retention Ratio (%) | 88.18 | 86.13 | 51.58 | 0.00 | -42.70 |
| Cash Earning Retention Ratio (%) | 92.59 | 90.46 | 70.42 | 0.00 | 4.30 |
| Interest Coverage Ratio (X) | 39.94 | 27.38 | 30.07 | 45.06 | 38.90 |
| Interest Coverage Ratio (Post Tax) (X) | 24.93 | 17.29 | 18.01 | 27.17 | 24.31 |
| Enterprise Value (Cr.) | 136725.29 | 132923.92 | 76710.60 | 70462.46 | 46861.76 |
| EV / Net Operating Revenue (X) | 3.90 | 4.01 | 1.97 | 2.43 | 1.91 |
| EV / EBITDA (X) | 15.85 | 17.57 | 13.09 | 10.74 | 8.59 |
| MarketCap / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| Retention Ratios (%) | 88.17 | 86.12 | 51.57 | 0.00 | -42.70 |
| Price / BV (X) | 2.48 | 3.25 | 2.29 | 2.96 | 2.17 |
| Price / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Ambuja Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.00. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.00, marking a decrease of 0.99.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 16.96, marking an increase of 0.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 28.84 (Mar 24) to 30.95, marking an increase of 2.11.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.28. It has decreased from 150.88 (Mar 24) to 142.28, marking a decrease of 8.60.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.02. This value is within the healthy range. It has increased from 34.43 (Mar 24) to 35.02, marking an increase of 0.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 24.95. This value is within the healthy range. It has decreased from 27.04 (Mar 24) to 24.95, marking a decrease of 2.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.99. This value is within the healthy range. It has decreased from 26.74 (Mar 24) to 23.99, marking a decrease of 2.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.89. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 20.89, marking a decrease of 0.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.92. This value is within the healthy range. It has increased from 16.27 (Mar 24) to 16.92, marking an increase of 0.65.
- For PBDIT Margin (%), as of Mar 25, the value is 24.61. This value is within the healthy range. It has increased from 22.81 (Mar 24) to 24.61, marking an increase of 1.80.
- For PBIT Margin (%), as of Mar 25, the value is 17.53. This value is within the healthy range. It has decreased from 17.92 (Mar 24) to 17.53, marking a decrease of 0.39.
- For PBT Margin (%), as of Mar 25, the value is 16.86. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 16.86, marking a decrease of 0.86.
- For Net Profit Margin (%), as of Mar 25, the value is 14.68. This value exceeds the healthy maximum of 10. It has increased from 14.21 (Mar 24) to 14.68, marking an increase of 0.47.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from 10.78 (Mar 24) to 11.89, marking an increase of 1.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.79. This value is below the healthy minimum of 15. It has decreased from 8.62 (Mar 24) to 7.79, marking a decrease of 0.83.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 11.17 (Mar 24) to 9.16, marking a decrease of 2.01.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has decreased from 5.47 (Mar 24) to 5.14, marking a decrease of 0.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.56 (Mar 24) to 0.47, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 2.05 (Mar 24) to 1.42, marking a decrease of 0.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.12, marking a decrease of 0.63.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.58. This value is below the healthy minimum of 4. It has decreased from 3.61 (Mar 24) to 3.58, marking a decrease of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.82. This value is below the healthy minimum of 20. It has decreased from 13.87 (Mar 24) to 11.82, marking a decrease of 2.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 20. It has decreased from 9.54 (Mar 24) to 7.41, marking a decrease of 2.13.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.18. This value exceeds the healthy maximum of 70. It has increased from 86.13 (Mar 24) to 88.18, marking an increase of 2.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.59. This value exceeds the healthy maximum of 70. It has increased from 90.46 (Mar 24) to 92.59, marking an increase of 2.13.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 39.94. This value is within the healthy range. It has increased from 27.38 (Mar 24) to 39.94, marking an increase of 12.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 24.93. This value is within the healthy range. It has increased from 17.29 (Mar 24) to 24.93, marking an increase of 7.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 136,725.29. It has increased from 132,923.92 (Mar 24) to 136,725.29, marking an increase of 3,801.37.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 4.01 (Mar 24) to 3.90, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 15.85. This value exceeds the healthy maximum of 15. It has decreased from 17.57 (Mar 24) to 15.85, marking a decrease of 1.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For Retention Ratios (%), as of Mar 25, the value is 88.17. This value exceeds the healthy maximum of 70. It has increased from 86.12 (Mar 24) to 88.17, marking an increase of 2.05.
- For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 3.25 (Mar 24) to 2.48, marking a decrease of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambuja Cements Ltd:
- Net Profit Margin: 14.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.16% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.79% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 24.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.12
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.6 (Industry average Stock P/E: 37.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Adani Corporate House, Shantigram, Near Vaishnavdevi Circle, Ahmedabad Gujarat 382421 | investors.relation@adani.com https://www.ambujacement.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gautam Adani | NonExeChairman&NonInd.Director |
| Mr. Ajay Kapur | Managing Director |
| Mr. Vinod Bahety | WholeTime Director & CEO |
| Mr. Karan Adani | Non Exe.Non Ind.Director |
| Mr. M R Kumar | Non Exe.Non Ind.Director |
| Mr. Rajnish Kumar | Ind. Non-Executive Director |
| Mr. Maheswar Sahu | Ind. Non-Executive Director |
| Ms. Purvi Sheth | Ind. Non-Executive Director |
| Mr. Ameet Desai | Ind. Non-Executive Director |
| Mr. Praveen Garg | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Ambuja Cements Ltd?
Ambuja Cements Ltd's intrinsic value (as of 25 November 2025) is 377.19 which is 31.17% lower the current market price of 548.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,35,345 Cr. market cap, FY2025-2026 high/low of 625/455, reserves of ₹55,752 Cr, and liabilities of 88,710 Cr.
What is the Market Cap of Ambuja Cements Ltd?
The Market Cap of Ambuja Cements Ltd is 1,35,345 Cr..
What is the current Stock Price of Ambuja Cements Ltd as on 25 November 2025?
The current stock price of Ambuja Cements Ltd as on 25 November 2025 is 548.
What is the High / Low of Ambuja Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambuja Cements Ltd stocks is 625/455.
What is the Stock P/E of Ambuja Cements Ltd?
The Stock P/E of Ambuja Cements Ltd is 23.6.
What is the Book Value of Ambuja Cements Ltd?
The Book Value of Ambuja Cements Ltd is 228.
What is the Dividend Yield of Ambuja Cements Ltd?
The Dividend Yield of Ambuja Cements Ltd is 0.37 %.
What is the ROCE of Ambuja Cements Ltd?
The ROCE of Ambuja Cements Ltd is 10.5 %.
What is the ROE of Ambuja Cements Ltd?
The ROE of Ambuja Cements Ltd is 8.73 %.
What is the Face Value of Ambuja Cements Ltd?
The Face Value of Ambuja Cements Ltd is 2.00.